Mar 21, 2024 at 9:34 PM#21
+1. This mirrors my journey exactly. The FAERS pharmacovigila discussion here is so valuable.
40 12LipidDoc_ATL, BariatricNurseD, MASHdoc_SA and 37 others
Reply Quote Save Share Report
Mar 21, 2024 at 9:51 PM#22
Slightly tangential to FAERS pharmacovigilance but MeganSA_TX reminded me — has anyone else noticed changes in their alcohol tolerance?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
4 15NurseKim_ATL, paul_denver, TinaHashiRN and 1 other
Reply Quote Save Share Report
Mar 21, 2024 at 10:08 PM#23
Saving this for reference. Top-tier content.
29 21alex_tucson, kevin_tulsa, Dr.PainCLE and 26 others
Reply Quote Save Share Report
Mar 21, 2024 at 10:25 PM#24
Slightly tangential to FAERS pharmacovigilance but MeganSA_TX reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
45 15james_edin, FranDenver, Dr.BariatricHTX and 42 others
Reply Quote Save Share Report
Mar 21, 2024 at 10:42 PM#25
Relevant to FAERS pharmacovigilance data — here is my latest bloodwork comparison:
Key improvements: A1C 7.2% → 5.3%, triglycerides 215 → 115 mg/dL, hsCRP 6.0 → 0.9 mg/L. All on tirzepatide for 7 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
31 16jason_sac26, chris_chi24, tampaLisa73 and 28 others
Reply Quote Save Share Report